News （Oct 12, 2019）:The President of H&J CRO International, Dr. Philip MENG addressed to all the colleagues declaring that H&J, after 6 months, 4 round bidding process with other 11 top China CRO competitors, H&J has successfully won the bide of a 35.5Million USD Oncology Project.
It is the biggest Phase III oncology clinical trial in China at present.
<tr id='cg9l6'><strong id='cg9l6'></strong><small id='cg9l6'></small><button id='cg9l6'></button><li id='cg9l6'><noscript id='cg9l6'><big id='cg9l6'></big><dt id='cg9l6'></dt></noscript></li></tr><ol id='cg9l6'><option id='cg9l6'><table id='cg9l6'><blockquote id='cg9l6'><tbody id='cg9l6'></tbody></blockquote></table></option></ol><u id='cg9l6'></u><kbd id='cg9l6'><kbd id='cg9l6'></kbd></kbd>